Cargando…
Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720353/ https://www.ncbi.nlm.nih.gov/pubmed/32406801 http://dx.doi.org/10.1177/1352458520921367 |
| _version_ | 1783619834587643904 |
|---|---|
| author | Bruijstens, Arlette L Blok, Katelijn M Smolders, Joost Wokke, Beatrijs HA Neuteboom, Rinze F |
| author_facet | Bruijstens, Arlette L Blok, Katelijn M Smolders, Joost Wokke, Beatrijs HA Neuteboom, Rinze F |
| author_sort | Bruijstens, Arlette L |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7720353 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77203532020-12-18 Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment Bruijstens, Arlette L Blok, Katelijn M Smolders, Joost Wokke, Beatrijs HA Neuteboom, Rinze F Mult Scler Letters SAGE Publications 2020-05-14 2020-12 /pmc/articles/PMC7720353/ /pubmed/32406801 http://dx.doi.org/10.1177/1352458520921367 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letters Bruijstens, Arlette L Blok, Katelijn M Smolders, Joost Wokke, Beatrijs HA Neuteboom, Rinze F Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment |
| title | Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment |
| title_full | Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment |
| title_fullStr | Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment |
| title_full_unstemmed | Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment |
| title_short | Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment |
| title_sort | pediatric ms patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular ms treatment |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720353/ https://www.ncbi.nlm.nih.gov/pubmed/32406801 http://dx.doi.org/10.1177/1352458520921367 |
| work_keys_str_mv | AT bruijstensarlettel pediatricmspatientswithaprimaryprogressivelikediseasemaystillhaverelevantinflammatoryactivityandmaybenefitfromregularmstreatment AT blokkatelijnm pediatricmspatientswithaprimaryprogressivelikediseasemaystillhaverelevantinflammatoryactivityandmaybenefitfromregularmstreatment AT smoldersjoost pediatricmspatientswithaprimaryprogressivelikediseasemaystillhaverelevantinflammatoryactivityandmaybenefitfromregularmstreatment AT wokkebeatrijsha pediatricmspatientswithaprimaryprogressivelikediseasemaystillhaverelevantinflammatoryactivityandmaybenefitfromregularmstreatment AT neuteboomrinzef pediatricmspatientswithaprimaryprogressivelikediseasemaystillhaverelevantinflammatoryactivityandmaybenefitfromregularmstreatment |